Acadia Pharmaceuticals (ACAD) Net Cash Flow (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Net Cash Flow of $102.7 million for Q2 2026, down 1.67% on a QoQ basis from $104.5 million in Q1 2026, and up 180.59% year-over-year from $36.6 million in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Net Cash Flow (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Net Cash Flow for 17 years, with the latest figure at $102.7 million in Q2 2026.
- On a quarterly basis, Net Cash Flow rose 180.59% year-over-year to $102.7 million in Q2 2026; TTM through Jun 2026 was $129.7 million, a 61.5% increase from a year earlier, with the FY2025 full-year figure at -$142.8 million, down 206.58% from the prior year.
- Net Cash Flow was $102.7 million for Q2 2026 at Acadia Pharmaceuticals, down from $104.5 million in the prior quarter.
- The five-year high for Net Cash Flow was $176.1 million in Q1 2023, with the low at -$180.6 million in Q2 2023.
- Average Net Cash Flow over 5 years is $13.3 million, with a median of $9.7 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow surged 366.79% in 2022, then slumped 733.51% in 2025.
- Over 5 years, Net Cash Flow stood at -$40.0 million in 2022, then soared by 326.26% to $90.5 million in 2023, then jumped by 81.82% to $164.5 million in 2024, then sank by 149.81% to -$81.9 million in 2025, then jumped by 225.4% to $102.7 million in 2026.
- The last three Net Cash Flow figures came in at $102.7 million (Q2 2026), $104.5 million (Q1 2026), and -$81.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -94.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | 102.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.75 Mn |
| Mar 31, 2026 | 104.49 Mn |
| Dec 31, 2025 | -81.93 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 36.62 Mn |
| Mar 31, 2025 | -101.89 Mn |
| Dec 31, 2024 | 164.50 Mn |
| Sep 30, 2024 | -18.94 Mn |
| Jun 30, 2024 | -27.61 Mn |
| Mar 31, 2024 | 16.08 Mn |
| Dec 31, 2023 | 90.48 Mn |
| Sep 30, 2023 | -12.09 Mn |
| Jun 30, 2023 | -180.60 Mn |
| Mar 31, 2023 | 176.05 Mn |
| Dec 31, 2022 | -39.99 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | -65.09 Mn |
| Mar 31, 2022 | 57.48 Mn |
| Dec 31, 2021 | 52.79 Mn |
| Sep 30, 2021 | -172.32 Mn |
API Access
Acadia Pharmaceuticals Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();